NNovartis Read More Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play2026-08-20 Quick Read AKTS retains full worldwide rights to its alpha-emitting cancer platform, with $517M cash and binary Q1…